188 related articles for article (PubMed ID: 10389927)
1. Loss of heterozygosity accumulation in primary breast carcinomas and additionally in corresponding distant metastases is associated with poor outcome.
Hampl M; Hampl JA; Reiss G; Schackert G; Saeger HD; Schackert HK
Clin Cancer Res; 1999 Jun; 5(6):1417-25. PubMed ID: 10389927
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
[TBL] [Abstract][Full Text] [Related]
3. Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases.
Lindblom A; Rotstein S; Skoog L; Nordenskjöld M; Larsson C
Cancer Res; 1993 Aug; 53(16):3707-11. PubMed ID: 8339280
[TBL] [Abstract][Full Text] [Related]
4. Location of several putative genes possibly involved in human breast cancer progression.
Driouch K; Briffod M; Bièche I; Champème MH; Lidereau R
Cancer Res; 1998 May; 58(10):2081-6. PubMed ID: 9605747
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.
Winqvist R; Hampton GM; Mannermaa A; Blanco G; Alavaikko M; Kiviniemi H; Taskinen PJ; Evans GA; Wright FA; Newsham I
Cancer Res; 1995 Jun; 55(12):2660-4. PubMed ID: 7780982
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer.
Wick W; Petersen I; Schmutzler RK; Wolfarth B; Lenartz D; Bierhoff E; Hümmerich J; Müller DJ; Stangl AP; Schramm J; Wiestler OD; von Deimling A
Oncogene; 1996 Mar; 12(5):973-8. PubMed ID: 8649814
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic significance of loss of heterozygosity in breast cancer].
Iwase H; Iwata H; Toyama T; Hara Y; Omoto Y; Kobayashi S
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():426-30. PubMed ID: 9589047
[TBL] [Abstract][Full Text] [Related]
8. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite alterations plasma DNA of primary breast cancer patients.
Shaw JA; Smith BM; Walsh T; Johnson S; Primrose L; Slade MJ; Walker RA; Coombes RC
Clin Cancer Res; 2000 Mar; 6(3):1119-24. PubMed ID: 10741742
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite analysis of breast carcinoma and corresponding local recurrences.
Regitnig P; Moser R; Thalhammer M; Luschin-Ebengreuth G; Ploner F; Papadi H; Tsybrovskyy O; Lax SF
J Pathol; 2002 Oct; 198(2):190-7. PubMed ID: 12237878
[TBL] [Abstract][Full Text] [Related]
11. Comparison of losses of heterozygosity and replication errors in primary colorectal carcinomas and corresponding liver metastases.
Bläker H; Graf M; Rieker RJ; Otto HF
J Pathol; 1999 Jul; 188(3):258-62. PubMed ID: 10419592
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas.
Utada Y; Haga S; Kajiwara T; Kasumi F; Sakamoto G; Nakamura Y; Emi M
Cancer; 2000 Mar; 88(6):1410-6. PubMed ID: 10717624
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer: metastatic patterns and their prognosis.
Patanaphan V; Salazar OM; Risco R
South Med J; 1988 Sep; 81(9):1109-12. PubMed ID: 3420442
[TBL] [Abstract][Full Text] [Related]
14. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
Taback B; Giuliano AE; Hansen NM; Singer FR; Shu S; Hoon DS
Cancer Res; 2003 Apr; 63(8):1884-7. PubMed ID: 12702578
[TBL] [Abstract][Full Text] [Related]
15. Metastatic site and p53 primary tumor expression in previously untreated stage IV breast cancer patients.
Paradiso A; Tommasi S; Barletta A; Leone B; Lacava J; Vellejo C; Labriola A; Marzullo F; Altieri R; Schittulli F; De Lena M
Anticancer Res; 1999; 19(5C):4523-8. PubMed ID: 10650804
[TBL] [Abstract][Full Text] [Related]
16. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity.
Yang TL; Su YR; Huang CS; Yu JC; Lo YL; Wu PE; Shen CY
Genes Chromosomes Cancer; 2004 Nov; 41(3):250-6. PubMed ID: 15334548
[TBL] [Abstract][Full Text] [Related]
17. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
18. The influence of basal phenotype on the metastatic pattern of breast cancer.
Luck AA; Evans AJ; Green AR; Rakha EA; Paish C; Ellis IO
Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):40-5. PubMed ID: 17981444
[TBL] [Abstract][Full Text] [Related]
19. Loss of BRCA2 correlates with reduced long-term survival of sporadic breast cancer patients.
Hampl JA; Hampl M; Reiss G; Koch R; Saeger HD; Schackert HK
Anticancer Res; 2004; 24(1):281-90. PubMed ID: 15015609
[TBL] [Abstract][Full Text] [Related]
20. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
Schwarzenbach H; Müller V; Stahmann N; Pantel K
Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
